Početna › Liposarkom › Ohio
Kliničke studije za Liposarkom u državi Ohio
6 studija za Liposarkom traži sudionike na lokacijama u državi Ohio.
Gradovi u državi Ohio
Službeni tekst studije (engleski)
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
- UH Seidman Cancer Center at UH Avon Health Center, Avon
- UHHS-Chagrin Highlands Medical Center, Beachwood
- Miami Valley Hospital South, Centerville
- i još 8
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06422806A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
- Investigative Site, Canton
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT06881992Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
- Ohio State University Comprehensive Cancer Center, Columbus
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 10. ruj 2026. · NCT04031677Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors
- Gabrail Cancer Center, Canton
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic Taussig Cancer Institute, Cleveland
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT06578624NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- Cincinnati Children's Hospital Medical Center, Cincinnati
U tijeku regrutacijaFaza 1/2
Do 30 godina · Oba spola · Ažurirano 3. kol 2026. · NCT06239272Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
- OSU James Hospital, Columbus
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 15. srp 2026. · NCT07377747Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.